Mechanisms of Drug Resistance in Mycobacterium tuberculosisBéate Heym(Hôpital Ambroise-Paré), W. Philipp(Institut Pasteur), S.T. Cole(Institut Pasteur)Current topics in microbiology and immunologyJanuary 1, 199610.1007/978-3-642-80166-2_3Cited by 382Open AccessFull TextSaveCiteExport RISWatch citationsAbstractRelated PapersThe curious characteristics of pyrazinamide: a review.Y Zhang, D.A. Mitchison|PubMed|2003|596Infectious multiple drug resistance.Stanley Falkow|Medical Entomology and Zoology|1975|326Activation of pyrazinamide and nicotinamide in acidic environments in vitro.Walsh McDermott, Ralph Tompsett|PubMed|1954|235Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coliDenan Jin, Carol A. Gross|Journal of Bacteriology|1989|164Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance.H. Traore, K. Fissette, I. Bastian et al.|PubMed|2000|154